Almond Supplementation and Exercise Recovery
Influence of Almond Supplementation on Energy, Performance, and Inflammation Resolution From Exercise-Induced Muscle Damage
1 other identifier
interventional
60
1 country
1
Brief Summary
The PURPOSE of this study is to see if eating almonds for four weeks will reduce muscle damage, soreness, and inflammation during several days of recovery from eccentric exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2021
CompletedFirst Submitted
Initial submission to the registry
June 17, 2021
CompletedFirst Posted
Study publicly available on registry
July 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedDecember 16, 2021
December 1, 2021
5 months
June 17, 2021
December 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum concentration of creatine kinase
Muscle damage biomarker
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
Secondary Outcomes (9)
Plasma concentrations of pro-inflammatory oxylipins: 19-hydroxy-eicosatetraenoic acid (HETE), 20-HETE, 20-cooh-AA, 8,9-dihydroxy-eicosatrienoic (all ng/ml) acid; (diHETrE), 14,15-diHETrE
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
Plasma concentration of IL-6
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
Urine almond metabolites: epicatechin, catechin, epiafzelechin, gallic acid, ellagic acid (all uM)
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
30-second Wingate cycle test watts
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
Leg-back strength kilograms
Change from pre-exercise to post-exercise (immediately after, and 1-, 2-, 3-, and 4-days after
- +4 more secondary outcomes
Study Arms (2)
Almond
EXPERIMENTAL57 g almonds each day in split doses (half in the morning, half in the afternoon)
Snack Bar
ACTIVE COMPARATORsnack bar group will ingest a matched calorie, common snack bar in split doses (324 calories/day, Nutri-Grain cereal bars, 120 kcal each)
Interventions
Eligibility Criteria
You may qualify if:
- Male or female, ages 30-65 years.
- Non-smoker.
- Body mass index of 23 to 30 kg/m2.
- Not engaged in regular weight lifting (less than 3 sessions per week).
- Agree to train normally, maintain weight, and avoid the regular use of protein supplements, large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation (especially Advil, Motrin, aspirin, and similar drugs) during the study.
- Categorized as "low risk" using a screening questionnaire.
- Generally healthy and without disease including heart disease, stroke, cancer, diabetes, arthritis.
- Willing to collect two 24-hour urine samples.
You may not qualify if:
- Inability to comply with study requirements.
- Engaged in regular weight training (3 or more times a week).
- Pregnant or breastfeeding.
- Any other condition that would interfere with successful completion of the study.
- Current diagnosis of heart disease, diabetes, or cancer (except for skin cancer).
- History of allergic reactions to almonds or cereal bars.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, 28081, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David C Nieman
Appalachian State Univ
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2021
First Posted
July 12, 2021
Study Start
June 16, 2021
Primary Completion
October 30, 2021
Study Completion
October 30, 2021
Last Updated
December 16, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share
Will provide data upon request.